Treatment outcome of new culture positive pulmonary tuberculosis in Norway (Q24793528)

6

object named as

Gunnar Bjune

0 references

author name string

Mohamed Guled Farah

1

0 references

Tore W Steen

3

0 references

Einar Heldal

4

0 references

Arne B Brantsaeter

https://scigraph.springernature.com/pub.10.1186/1471-2458-5-14

5

0 references

language of work or name

English

0 references

publication date

7 February 2005

0 references

published in

BMC Public Health

0 references

volume

5

0 references

issue

1

0 references

page(s)

14

0 references

exact match

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2458-5-14

cites work

Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549556

European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549556

Molecular epidemiology of Mycobacterium tuberculosis in Norway

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549556

Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549556

Deaths from pulmonary tuberculosis in a low-incidence country.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549556

Results in pulmonary tuberculosis patients under various treatment program conditions

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549556

Risk factors for recent transmission of Mycobacterium tuberculosis

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2458-5-14

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2458-5-14

Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549556

[Shortages in Swedish tuberculosis care. Good results only in 71 percent of cases after 12-month treatment as shown in a current study]

28 November 2018

1 reference

12 December 2020

A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates

1 reference

12 December 2020

Tuberculosis diagnosed at death in the United States

1 reference

12 December 2020

Deaths in tuberculosis patients in British Columbia, 1980–1984

1 reference

12 December 2020

Why do our patients die of active tuberculosis in the era of effective therapy?

1 reference

12 December 2020

Outcome of patients treated for tuberculosis in Vaud County, Switzerland

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2458-5-14

1 reference

Dimensions Publication ID

4344510

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2458-5-14

4344510

1 reference

1 reference

1 reference